Every article, report, and earnings note where MDLN appears.
2 articles
Medline is growing at scale with strong customer retention and a deep med-surg distribution network, but margin pressure and a rich valuation keep the stock from looking cheap.
Medline Inc. (MDLN) drops sharply after its Q1 2026 earnings report showed strong revenue growth but weaker profitability. Investors are reacting to margin compression from tariffs, higher operating costs, and IPO-related expenses, even as full-year sales guidance improved.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate MDLN Report